ND0612H
Phase 2- Indications
- Severe Parkinson's disease
Company intelligence / Profile preview
InSight Biopharmaceuticals Ltd.
Israelkenes-exhibitions.com ↗
- Ownership
- Private
- Employees
- ~250
- Development stage
- Phase 3
01
Overview
InSight Biopharmaceuticals has successfully launched high-value biosimilars in key markets through strategic partnerships. Its portfolio includes both bulk drug substances and finished drug products for biosimilars and complex generics. At least one product targeting multiple sclerosis via the IFNAR pathway has achieved approval status as of January 2015.
- Therapeutic areas
- OtherImmunologyNeurology
- Modalities
- Biosimilars (biologic drugs similar to approved reference products)Complex genericsInterferonsHormones
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Strategic alliances for commercialization of biosimilars in key markets have been referenced, but specific partners are not named publicly.
Beyond the preview
Go deeper on InSight Biopharmaceuticals Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InSight Biopharmaceuticals Ltd..